The Center for Translational Genomic Phenotyping
The Center for Translational Genomic Phenotyping
批准号:
8137289
负责人:
Robert D Cardiff
金额:
$69.54万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-08-31
关键词:
AbateAcademyBioinformaticsCaliforniaCancer BiologyCancer ModelClinical Laboratory Information SystemsCollaborationsCommunicationCommunitiesConsultationsCountryDataData DisplayDevelopmentDiagnosisEducational workshopElectronicsFosteringGenomicsGoalsHumanImageInformaticsInterventionKnockout MiceLeadershipMalignant NeoplasmsMapsModelingMouse Models of Human Cancer ConsortiumMusMutant Strains MiceNational Cancer InstitutePathologicPathologistPathologyPhenotypePilot ProjectsPre-Clinical ModelPredispositionPreventionRadiology SpecialtyResearchResearch InfrastructureResearch Project GrantsResourcesScienceSlideStagingSystemTherapeuticTranslationsUniversitiesValidationVisitWorkauthoritycancer Biomedical Informatics Gridcomparativedesignexperiencehuman diseaseimage archival systemin vivomouse modeloutreachprofessorprogramsrepositorysymposiumtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The University of California (UC), Davis Center for Translational Genomic Phenotyping (CTGP): A National Cancer Institute-Mouse Models of Human Cancer Consortium (NCI-MMHCC) Science Leadership Application will provide centralized discovery-driven in-vivo and ex-vivo phenotyping for validation of model pathology. This is predominantly centered on Cancer Biology, but Impacts Preventative Interventions, Experimental Therapeutics and Cancer Susceptibility programs as well. The application is organized in five sections. 1. As a Summary of the Research, the PI, Dr. Robert Cardiff, is a Co-Pl, Co-I and collaborator on several past and newly submitted MMHCC research projects. He Is Co-l on "Goal 1" research applications submitted with Lewis Chodosh, Cory Abate-Shen, and Robert Schreiber. He has consistently provided consultation and leadership within the MMHCC Consortium with respect to phenotypes, translation of pathologic findings in the mouse to the human disease, and defining and publicizing criteria for diagnosis, staging and grading critical to the use of the mouse models in cancer biology, prevention, and experimental therapeutics. 2. The Leadership Plan will A) electronically coordinate intra-NCI-MMHCC projects in the specific research clusters of Preventative Interventions and Cancer Biology and anticipate fostering collaborations among the U0l awardees who are affiliated with these research clusters; B) foster collaborations throughout the MMHCC and with other NCI networks and consortia to delineate research resources or pilot projects that promote the cluster collaborations; and C) manage and enhance the existing NCI cancer model bioinformatics infrastructure through caELMIR with Integrated image archives of in-vivo and ex-vivo images that are accurately mapped to relevant human bioinformatics systems in collaboration. 3. The Communication and Coordination will be achieved through the informatics tools connecting the MMHCC research affiliates with the expert pathology/phenotyping resource embodied In the Academy for Genomic Pathology. This group constitutes most of the leading authorities and most experienced mouse model and comparative pathologists in the country. 4. Outreach will be achieved through symposia and workshops, as well as an open visiting trainee/ visiting professor program at the UC Davis center. In addition, the connections at UC Davis to the Mutant Mouse Regional Resource Center, and the Knockout Mouse Project Repository provide added outreach to the mouse modeling community. 5. Pre-Clinical Models Informatics for the MMHCC and the NCI has been developed, in part, by our group at UC Davis. Studies have been Initiated at UC Davis, and specific pilot projects designs demanding accurate integrated data from mouse colony management, pathology laboratory information systems, whole slide images, radiology image data and display and electronic "lab notebooks" using caELMIR, caMOD, and the caBIG infrastructure. This application is uniquely relevant to the program priorities. This is a Leadership U01 centered on phenotyping and pathology, with extensive support from a host of national experts In mouse pathology, and extensive background and preliminary work In development of Informatics uniquely designed to the purposes of the MMHCC consortium
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Center for Translational Genomic Phenotyping
-
批准号:7741866
-
项目类别:
-
资助金额:$74.34万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance
-
批准号:8537378
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
The Center for Translational Genomic Phenotyping
-
批准号:7923217
-
项目类别:
-
资助金额:$74.16万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
The Center for Translational Genomic Phenotyping
-
批准号:8327686
-
项目类别:
-
资助金额:$67.18万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance
-
批准号:8329653
-
项目类别:
-
资助金额:$74.3万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance
-
批准号:7740572
-
项目类别:
-
资助金额:$82.5万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
The Center for Translational Genomic Phenotyping
-
批准号:8546997
-
项目类别:
-
资助金额:$61.03万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance
-
批准号:7916528
-
项目类别:
-
资助金额:$82.02万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance
-
批准号:8136118
-
项目类别:
-
资助金额:$76.11万
-
财政年份:2009
-
负责人:Robert D Cardiff
-
依托单位:
25TH IABCR CONGRESS CONFERENCE: PERSONALIZED BREAST CANCER THERAPY
-
批准号:7167611
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2006
-
负责人:Robert D Cardiff
-
依托单位:
PRECLINICAL MODELS OF BREAST CANCER
-
批准号:6717389
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2003
-
负责人:Robert D Cardiff
-
依托单位:
BIOLOGY OF NEOPLASTIC TRANSFORMATION IN BREAST CANCER
-
批准号:6626781
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2001
-
负责人:Robert D Cardiff
-
依托单位:
BIOLOGY OF NEOPLASTIC TRANSFORMATION IN BREAST CANCER
-
批准号:6228389
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2001
-
负责人:Robert D Cardiff
-
依托单位:
BIOLOGY OF NEOPLASTIC TRANSFORMATION IN BREAST CANCER
-
批准号:6691669
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2001
-
负责人:Robert D Cardiff
-
依托单位:
BIOLOGY OF NEOPLASTIC TRANSFORMATION IN BREAST CANCER
-
批准号:6489405
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2001
-
负责人:Robert D Cardiff
-
依托单位:
BIOLOGY OF NEOPLASTIC TRANSFORMATION IN BREAST CANCER
-
批准号:6839398
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2001
-
负责人:Robert D Cardiff
-
依托单位:
MOUSE MODELS FOR PROSTATE CARCINOGENESIS
-
批准号:2101541
-
项目类别:
-
资助金额:$29.51万
-
财政年份:1994
-
负责人:Robert D Cardiff
-
依托单位:
MOUSE MODELS FOR PROSTATE CARCINOGENESIS
-
批准号:2376890
-
项目类别:
-
资助金额:$32.4万
-
财政年份:1994
-
负责人:Robert D Cardiff
-
依托单位:
MOUSE MODELS FOR PROSTATE CARCINOGENESIS
-
批准号:2101542
-
项目类别:
-
资助金额:$31.15万
-
财政年份:1994
-
负责人:Robert D Cardiff
-
依托单位:
MOUSE MODELS FOR PROSTATE CARCINOGENESIS
-
批准号:2101540
-
项目类别:
-
资助金额:$29.68万
-
财政年份:1994
-
负责人:Robert D Cardiff
-
依托单位:
海外基金